Prescription Drugs

November 19, 2025 | Controlled Substances, Drug Courts, Harm Reduction, Law Enforcement, Legal & Legislative Research, Opioids, Prescription Drugs, Public Health, Public Safety, Substance Misuse

Psilocybin is a chemical compound produced by more than 100 species of mushrooms found growing around the world. Because of the psychedelic effects that these mushrooms produce when consumed, psilocybin-containing mushrooms have been colloquially referred to as “magic mushrooms” or “shrooms.” In this document, the Legislative Analysis and Public Policy Association (LAPPA) identifies both currently-in-force statutes/regulations and recently proposed legislation related to psilocybin throughout all 50 states, the District of Columbia, and the U.S. territories....

August 28, 2025 | Controlled Substances, Law Enforcement, Legal & Legislative Research, Prescription Drugs, Public Safety

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the state-level legislative response to drugged driving. This document includes a summary of existing laws on driving under the influence of drugs in the 50 states and the District of Columbia as well as a list of pending state and federal legislation....

August 11, 2025 | Controlled Substances, Harm Reduction, Legal & Legislative Research, Opioids, Pharmacy, Prescription Drugs, Public Health, Public Safety, Substance Misuse

In this document, the Legislative Analysis and Public Policy Association examines state-level legislative and administrative responses to the public health risk posed by expired and unused prescription medications. In the last several years, states, in coordination with the Federal Drug Enforcement Administration (DEA) have enacted legislation or promulgated administrative regulations to authorize drug take-back programs where expired or unused pharmaceuticals can be collected from the public by authorized persons and disposed of in a safe manner. Findings are presented by state for ease of comparison....

August 8, 2025 | Controlled Substances, Legal & Legislative Research, Opioids, Prescription Drugs, Substance Misuse, Synthetic Drugs

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the policy response at the state level to the spread of pill presses used to create counterfeit drugs. There is relatively little policy in this area compared to federal law, and most innovation is relatively recent.  Findings are presented jurisdiction by jurisdiction for easy comparison among states and between current state- and federal law....

July 30, 2025 | Cannabidiol (CBD), Controlled Substances, Fact Sheets, Marijuana, Prescription Drugs, Substance Misuse, Synthetic Drugs

In this fact sheet, LAPPA examines the features of the Snapchat app that can facilitate online drug transactions, the theory and progression of a major lawsuit against Snap brought by parents of overdose victims, and other recent legal and legislative actions taken against Snap for its alleged role in online drug sales....

April 16, 2025 | Controlled Substances, Fact Sheets, Prescription Drugs, Public Safety, Substance Misuse

This fact sheet provides updated information (as of April 2025) on the issue of drug diversion in health care settings. Drug diversion is defined as any criminal act or deviation that removes a prescription drug from its intended path from the manufacturer to the patient, and while the act of diversion can occur in a variety of settings and be committed by anyone, it is particularly likely to occur in healthcare settings by healthcare workers due to the ease in which they can access prescription drugs. Drug diversion in health care is a serious issue that can result in patient harm, financial loss to the healthcare entity, and civil and criminal litigation based on the perpetrator’s actions....

June 28, 2024 | Controlled Substances, Fetal and Infant Health, Legal & Legislative Research, Maternal Health, Opioids, Prescription Drugs, Substance Misuse, Treatments

In this document, the Legislative Analysis and Public Policy Association (LAPPA) examines state-level statutes and regulations related to substance use during pregnancy and whether such use during pregnancy is considered child abuse or neglect in the jurisdiction. ...